Applications are open
Apply Today
The discovery and use of antibiotics is one of public health’s great achievements, but antibiotic use is not without its problems. At therapeutic doses, antibiotics exert a strong selection pressure on the microbial community. When antibiotics interact with an infant’s developing microbiome, they can affect gut health and with it the child’s health for years to come.
Children with epidermolysis bullosa are often called butterfly children—their skin seems to be as fragile as a butterfly’s wing. While there is no cure for EB, ongoing clinical trials have developed treatments to manage symptoms. Public health clinicians can help patients and their families build support networks by connecting them to local support groups and other families caring for children with EB.
The constant demands of caregiving can create physical and psychological stress with little opportunity for adaptation, potentially resulting in negative physical and mental health outcomes for the caregiver. These burdens can be reduced by following proper measures for self-management.
Chloroquine and hydroxychloroquine are important therapies for those suffering from lupus, a complex auto-immune disease. As the world battles to overcome COVID-19, we must ensure continued availability of antimalarials to patients whose lives literally depend on them.
Ultimately, vaccines are beneficial, and human trials are essential in determining the safety of any vaccine. But how do we select candidates for vaccine tests? Fallout from unethical experiments is persistent, and we must insist on the most ethical and medically accurate appraisals of the vaccine landscape.
For years we have known that the US does not have a sufficient health care workforce to provide adequate health care for older adults. The current pandemic makes the situation all the more pressing. Now is the time to revisit and revise our policies and practices to reduce the burden of suffering for older Americans and their caregivers.